Gluomni M1 for Pharmacists, Doctors and Distributors
Gluomni M1: Metformin Hydrochloride (SR) & Glimepiride Tablets IP
Practical notes for prescribers, pharmacists and distributors handling Gluomni M1: regulatory status, counselling checklist, pharmacy storage and supply enquiries.
Gluomni M1 Product Profile at a Glance
- Brand: Gluomni M1, marketed by EMK Omni Pharma, Mysuru, Karnataka
- Generic: Metformin Hydrochloride (SR) and Glimepiride Tablets IP
- Composition: Metformin Hydrochloride IP 500 mg in sustained release form with Glimepiride IP 1 mg and approved excipients
- Dosage form: uncoated bilayer tablet
- Pack: 10 x 10 tablets
- Therapeutic category: Diabetes Care
- Regulatory status: Schedule G and Schedule H
- Storage: cool, dry, dark place, protected from light
EMK Omni Pharma markets the brand. Manufacture is carried out at GMP certified contract manufacturing units on the company's behalf, and batch details are printed on both the carton and the blister foil.
Schedule G and Schedule H Handling at the Counter
The label carries the Schedule G caution that it is dangerous to take this preparation except under medical supervision, together with the Schedule H statement that it is not to be sold by retail without the prescription of a registered medical practitioner.
In practice this means the prescription should be legible and dated, should identify the prescriber with qualification and registration details, should name the patient, and should specify the product or generic with strength and quantity. Retain records as required under the Drugs and Cosmetics Rules and your state licensing authority's directions.
Dispense the exact strength written. Because a related brand carries a different Glimepiride content, any substitution or dose change should be referred back to the prescriber rather than settled at the counter. Note the batch number and expiry against the sale so that a query or recall can be traced quickly.
Patient Counselling Checklist for Gluomni M1
Run through these points at the time of dispensing, ideally in the patient's own language:
- Take the tablet with or just after a meal, exactly as the doctor has directed; do not take it and then skip the meal
- Swallow the tablet whole with water; do not chew, crush or split the bilayer sustained release tablet
- Keep the timing consistent each day, tied to the same meal
- Recognise low blood sugar: sweating, tremor, palpitations, sudden hunger, dizziness, irritability or confusion; treat with fast acting glucose and follow with a meal
- Carry glucose powder or sugar sachets, especially when travelling or fasting
- Do not double up after a missed dose
- Report persistent vomiting, diarrhoea, poor oral intake or fever, since Metformin may need to be paused
- Inform every doctor and radiology department that they are on a Metformin containing product before contrast studies or surgery
- Alcohol raises the risk of both hypoglycaemia and lactic acidosis
- Keep the carton out of reach of children and away from moisture
A short demonstration of glucometer use and a written note of the doctor's contact number add real value.
Clinical Points Worth Repeating to Prescribing Colleagues
Renal function guides eligibility and continuation for the Metformin component; document eGFR at initiation and review periodically, with closer intervals in older adults and in those on diuretics, renin angiotensin blockers or long term anti inflammatory painkillers.
The 1 mg Glimepiride content suits cautious initiation, elderly patients, those with irregular meal timings and those stepping down after hypoglycaemic episodes. Counsel on hypoglycaemia unawareness, particularly where beta blockers are co prescribed.
Withhold Metformin around iodinated contrast administration and major surgery, and restart after renal function has been reassessed and oral intake is established. Consider periodic vitamin B12 assessment during prolonged Metformin therapy, especially where peripheral neuropathy is being evaluated. Review the plan in pregnancy, planned pregnancy and breastfeeding.
Storage and Stock Rotation at the Pharmacy
Keep cartons in a cool, dry and dark area of the pharmacy, protected from light and away from direct sunlight through shop front glass. Shelving should sit above floor level, particularly during the monsoon, and away from air conditioner drainage, water pipes and washroom walls.
Rotate stock on a first expiry, first out basis and check shelves monthly for near expiry cartons. Avoid cutting strips wherever possible; where a part strip is dispensed, ensure the batch number and expiry remain visible on the portion handed over.
Inspect incoming consignments for crushed cartons, water staining or damaged foil, and quarantine anything doubtful. Maintain a temperature and humidity log for the storage area if your licensing authority requires it, and keep near expiry and returned stock in a clearly marked separate area.
Availability and Trade Enquiries
Pharmacies, clinics, hospitals, stockists and distributors can raise availability and supply enquiries for Gluomni M1 and the wider EMK Omni Pharma Diabetes Care range directly with the company.
- Website and contact page: emkomnipharma.com
- WhatsApp: +91 94487 74372
- Email: info@emkomnipharma.com
Please include your firm name, drug licence details, delivery city and the pack quantity you require so the team can respond usefully. Batch specific queries, complaint reporting and product information requests can be sent through the same channels, quoting the batch number and expiry printed on the carton.
Healthcare professionals are encouraged to report suspected adverse drug reactions through the national pharmacovigilance route as well as to the company.
This article is for general information only and is not a substitute for advice from a registered medical practitioner.
Frequently asked questions
- What prescription details should a pharmacist verify for Gluomni M1?
- A legible, dated prescription naming the patient and the prescriber with registration details, specifying the product or generic, the strength and the quantity, in line with Schedule H requirements.
- Can a chemist substitute Gluomni M1 with a different Glimepiride strength?
- No. A related brand carries a different Glimepiride content, so any change in strength must be referred back to the prescriber.
- Which counselling point is most often missed?
- That the tablet is meal linked. Patients who take it and then skip the meal are the ones most likely to report hypoglycaemic symptoms.
- How should a pharmacy store the cartons?
- In a cool, dry, dark area above floor level, away from direct sunlight and damp walls, with first expiry first out rotation and monthly shelf checks.
- How can a distributor enquire about supply?
- Through the contact page on emkomnipharma.com, WhatsApp on +91 94487 74372, or email to info@emkomnipharma.com, quoting firm name, licence details and city.
- Does EMK Omni Pharma manufacture Gluomni M1 itself?
- EMK Omni Pharma markets the brand. Manufacturing is carried out at GMP certified contract manufacturing units on the company's behalf.
Need Gluomni M1 for your pharmacy, hospital or clinic?
EMK Omni Pharma supplies through authorised channels across Karnataka. Send an enquiry and our team will respond during business hours.
Related guides
Medical Disclaimer
This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.


